The role of telomeres and telomerase reverse transcriptase isoforms in pluripotency induction and maintenance

RNA Biology

Volumn 13, Issue 8, 2016, Pages 707-719

  Teichroeb, Jonathan H ^a   Kim, Joohwan ^a   Betts, Dean H ^a,b  

^a WESTERN UNIVERSITY   (Canada)

^b CHILDREN S HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Alternative splicing; embryonic stem cells; hESC; iPSC; pluripotency; telomerase; telomere; TERT

Indexed keywords

BRG1 PROTEIN; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; WNT PROTEIN; BIOLOGICAL MARKER; ISOENZYME; PROTEIN BINDING;

ALTERNATIVE RNA SPLICING; ENZYME ACTIVITY; HUMAN; INDUCED PLURIPOTENT STEM CELL; MITOCHONDRION; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TELOMERE; TELOMERE HOMEOSTASIS; ANIMAL; CELL SELF-RENEWAL; CYTOLOGY; EMBRYONIC STEM CELL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

ALTERNATIVE SPLICING; ANIMALS; BIOMARKERS; CELL SELF RENEWAL; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; HUMANS; ISOENZYMES; MITOCHONDRIA; PLURIPOTENT STEM CELLS; PROTEIN BINDING; TELOMERASE; TELOMERE;

EID: 84969752477     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.1080/15476286.2015.1134413     Document Type: Review

References (163)

1. H.J.Muller. The Remaking of Chromosomes. Collecting Net - Woods Hole 1938; 13:181-98
2. B.McClintock. The stability of broken ends of chromosomes in Zea mays. Genetics 1941; 26:234-82; PMID:17247004
3. S.R.Chan, E.H.Blackburn. Telomeres and telomerase. Philos Trans R Soc Lond B Biol Sci 2004; 359:109-21; PMID:15065663; http://dx.doi.org/10.1098/rstb.2003.1370
4. L.Hayflick. The Limited in Vitro Lifetime of Human Diploid Cell Strains. Exp Cell Res 1965; 37:614-36; PMID:14315085; http://dx.doi.org/10.1016/0014-4827(65)90211-9
5. L.Hayflick, P.S.Moorhead. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25:585-621; PMID:13905658; http://dx.doi.org/10.1016/0014-4827(61)90192-6
6. M.Armanios. Telomerase and idiopathic pulmonary fibrosis. Mutat Res 2012; 730:52-58; http://dx.doi.org/10.1016/j.mrfmmm.2011.10.013
7. M.Y.Armanios, J.J.Chen, J.D.Cogan, J.K.Alder, R.G.Ingersoll, C.Markin, W.E.Lawson, M.Xie, I.Vulto, J.A.Phillips3rd, et al. Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis. New England Journal of Medicine 2007; 356:1317-26; PMID:17392301; http://dx.doi.org/10.1056/NEJMoa066157
8. A.Aviv. Genetics of leukocyte telomere length and its role in atherosclerosis. Mutat Res 2012; 730:68-74; http://dx.doi.org/10.1016/j.mrfmmm.2011.05.001
9. H.Yamaguchi, R.T.Calado, H.Ly, S.Kajigaya, G.M.Baerlocher, S.J.Chanock, P.M.Lansdorp, N.S.Young. Mutations in TERT, the Gene for Telomerase Reverse Transcriptase, in Aplastic Anemia. New England Journal of Medicine 2005; 352:1413-24; PMID:15814878; http://dx.doi.org/10.1056/NEJMoa042980
10. L.Carulli, C.Anzivino. Telomere and telomerase in chronic liver disease and hepatocarcinoma. World Journal of Gastroenterology:WJG 2014; 20:6287-92; PMID:24876749; http://dx.doi.org/10.3748/wjg.v20.i20.6287
11. T.Biron-Shental, R.Sukenik-Halevy, Y.Sharon, L.Goldberg-Bittman, D.Kidron, M.D.Fejgin, A.Amiel. Short telomeres may play a role in placental dysfunction in preeclampsia and intrauterine growth restriction. American journal of obstetrics and gynecology 2010; 202:381-e1; PMID:20350645; http://dx.doi.org/10.1016/j.ajog.2010.01.036
12. T.Biron-Shental, R.Sukenik Halevy, L.Goldberg-Bittman, D.Kidron, M.D.Fejgin, A.Amiel. Telomeres are shorter in placental trophoblasts of pregnancies complicated with intrauterine growth restriction (IUGR). Early human development 2010; 86:451-6; PMID:20619976; http://dx.doi.org/10.1016/j.earlhumdev.2010.06.002
13. T.Biron-Shental, D.Kidron, R.Sukenik-Halevy, L.Goldberg-Bittman, R.Sharony, M.D.Fejgin, A.Amiel. TERC telomerase subunit gene copy number in placentas from pregnancies complicated with intrauterine growth restriction. Early human development 2011; 87:73-5; PMID:21168289; http://dx.doi.org/10.1016/j.earlhumdev.2010.08.024
14. C.W.Greider, E.H.Blackburn. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985; 43:405-13; PMID:3907856; http://dx.doi.org/10.1016/0092-8674(85)90170-9
15. E.H.Blackburn, K.Collins. Telomerase:an RNP enzyme synthesizes DNA. Cold Spring Harb Perspect Biol 2011; 3:a003558; PMID:20660025; http://dx.doi.org/10.1101/cshperspect.a003558
16. S.E.Artandi, R.A.DePinho. Telomeres and telomerase in cancer. Carcinogenesis 2010; 31:9-18; PMID:19887512; http://dx.doi.org/10.1093/carcin/bgp268
17. C.Autexier, C.W.Greider. Telomerase and cancer:revisiting the telomere hypothesis. Trends Biochem Sci 1996; 21:387-91; PMID:8918193; http://dx.doi.org/10.1016/S0968-0004(96)10042-6
18. X.Xie, A.Hiona, A.S.Lee, F.Cao, M.Huang, Z.Li, A.Cherry, X.Pei, J.C.Wu. Effects of long-term culture on human embryonic stem cell aging. Stem Cells Dev 2010; 20:127-38; PMID:20629482; http://dx.doi.org/10.1089/scd.2009.0475
19. Y.Huang, P.Liang, D.Liu, J.Huang, Z.Songyang. Telomere regulation in pluripotent stem cells. Protein Cell 2014; 5:194-202; PMID:24563217; http://dx.doi.org/10.1007/s13238-014-0028-1
20. K.Kalmbach, L.G.Robinson, Jr, F.Wang, L.Liu, D.Keefe. Telomere length reprogramming in embryos and stem cells. Biomed Res Int 2014; 2014:925121; PMID:24719895; http://dx.doi.org/10.1155/2014/925121
21. F.A.Gourronc, A.J.Klingelhutz. Therapeutic opportunities:Telomere maintenance in inducible pluripotent stem cells. Mutat Res 2012 730:98-105; PMID:21605571; http://dx.doi.org/10.1016/j.mrfmmm.2011.05.008
22. J.Huang, F.Wang, M.Okuka, N.Liu, G.Ji, X.Ye, B.Zuo, M.Li, P.Liang, W.W.Ge, et al. Association of telomere length with authentic pluripotency of ES/iPS cells. Cell Res 2011; 21:779-92; PMID:21283131; http://dx.doi.org/10.1038/cr.2011.16
23. D.L.Keefe, S.Franco, L.Liu, J.Trimarchi, B.Cao, S.Weitzen, S.Agarwal, M.A.Blasco. Telomere length predicts embryo fragmentation after in vitro fertilization in women–toward a telomere theory of reproductive aging in women. Am J Obstet Gynecol 2005; 192:1256-60; discussion 1260–1; PMID:15846215; http://dx.doi.org/10.1016/j.ajog.2005.01.036
24. I.Listerman, J.Sun, F.S.Gazzaniga, J.L.Lukas, E.H.Blackburn. The major reverse transcriptase–incompetent splice variant of the human telomerase protein inhibits telomerase activity but protects from apoptosis. Cancer Res 2013; 73:2817-28; PMID:23610451; http://dx.doi.org/10.1158/0008-5472.CAN-12-3082
25. R.Hrdlickova, J.Nehyba, H.R.Bose, Jr. Alternatively spliced telomerase reverse transcriptase variants lacking telomerase activity stimulate cell proliferation. Mol Cell Biol 2012; 32:4283-96; PMID:22907755; http://dx.doi.org/10.1128/MCB.00550-12
26. R.C.Allsopp, H.Vaziri, C.Patterson, S.Goldstein, E.V.Younglai, A.B.Futcher, C.W.Greider, C.B.Harley. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A 1992; 89:10114-8; PMID:1438199; http://dx.doi.org/10.1073/pnas.89.21.10114
27. M.Amit, M.K.Carpenter, M.S.Inokuma, C.P.Chiu, C.P.Harris, M.A.Waknitz, J.Itskovitz-Eldor, J.A.Thomson. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 2000; 227:271-278; PMID:11071754; http://dx.doi.org/10.1006/dbio.2000.9912
28. H.Vaziri, K.B.Chapman, A.Guigova, J.Teichroeb, M.D.Lacher, H.Sternberg, I.Singec, L.Briggs, J.Wheeler, J.Sampathkumar, et al. Spontaneous reversal of the developmental aging of normal human cells following transcriptional reprogramming. Regenerative Medicine 2010; 5:345-63; PMID:20230312; http://dx.doi.org/10.2217/rme.10.21
29. T.Winkler, S.G.Hong, J.E.Decker, M.J.Morgan, C.Wu, W.M.Hughes5th, Y.Yang, D.Wangsa, H.M.Padilla-Nash, T.Ried, et al. Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs. J Clin Investig 2013; 123:1952-63; http://dx.doi.org/10.1172/JCI67146
30. S.T.Suhr, E.A.Chang, R.M.Rodriguez, K.Wang, P.J.Ross, Z.Beyhan, S.Murthy, J.B.Cibelli. Telomere dynamics in human cells reprogrammed to pluripotency. PLoS ONE 2009; 4:e8124; PMID:19956585; http://dx.doi.org/10.1371/journal.pone.0008124
31. G.Ji, W.Ruan, K.Liu, F.Wang, D.Sakellariou, J.Chen, Y.Yang, M.Okuka, J.Han, Z.Liu, et al. Telomere reprogramming and maintenance in porcine iPS cells. PLoS ONE 2013; 8:e74202; PMID:24098638; http://dx.doi.org/10.1371/annotation/f5e4554b-18cc-46ef-ac39-73ac4d6750ae
32. R.Mathew, W.Jia, A.Sharma, Y.Zhao, L.E.Clarke, X.Cheng, H.Wang, U.Salli, K.E.Vrana, G.P.Robertson, et al. Robust activation of the human but not mouse telomerase gene during the induction of pluripotency. FASEB J 2010; 24:2702-15; PMID:20354136; http://dx.doi.org/10.1096/fj.09-148973
33. F.Wang, Y.Yin, X.Ye, K.Liu, H.Zhu, L.Wang, M.Chiourea, M.Okuka, G.Ji, J.Dan, et al. Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells. Cell Res 2012; 22:757-68; PMID:22184006; http://dx.doi.org/10.1038/cr.2011.201
34. S.Yehezkel, A.Rebibo-Sabbah, Y.Segev, M.Tzukerman, R.Shaked, I.Huber, L.Gepstein, K.Skorecki, S.Selig. Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives. Epigenetics 2011; 6:63-75; PMID:20861676; http://dx.doi.org/10.4161/epi.6.1.13390
35. K.D.Park, S.K.Seong, Y.M.Park, Y.Choi, J.H.Park, S.H.Lee, D.H.Baek, J.W.Kang, K.S.Choi, S.N.Park, et al. Telomerase reverse transcriptase related with telomerase activity regulates tumorigenic potential of mouse embryonic stem cells. Stem Cells Dev 2010; 20:149-57; PMID:20486780; http://dx.doi.org/10.1089/scd.2009.0523
36. S.E.Holt, W.E.Wright, J.W.Shay. Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 1996; 16:2932-9; PMID:8649404; http://dx.doi.org/10.1128/MCB.16.6.2932
37. W.E.Wright, M.A.Piatyszek, W.E.Rainey, W.Byrd, J.W.Shay. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 1996; 18:173-9; PMID:8934879; http://dx.doi.org/10.1002/(SICI)1520-6408(1996)18:2%3c173::AID-DVG10%3e3.0.CO;2-3
38. Y.Zhao, A.J.Sfeir, Y.Zou, C.M.Buseman, T.T.Chow, J.W.Shay, W.E.Wright. Telomere extension occurs at most chromosome ends and is uncoupled from fill-in in human cancer cells. Cell 2009; 138:463-75; PMID:19665970; http://dx.doi.org/10.1016/j.cell.2009.05.026
39. L.Lapasset, O.Milhavet, A.Prieur, E.Besnard, A.Babled, N.Aït-Hamou, J.Leschik, F.Pellestor, J.M.Ramirez, J.De Vos, et al. Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Gen Dev 2011; 25:2248-53; PMID:22056670; http://dx.doi.org/10.1101/gad.173922.111
40. S.Agarwal, Y.H.Loh, E.M.McLoughlin, J.Huang, I.H.Park, J.D.Miller, H.Huo, M.Okuka, R.M.Dos Reis, S.Loewer, et al. Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature 2010; 464:292-6; PMID:20164838; http://dx.doi.org/10.1038/nature08792
41. M.T.Hemann, M.A.Strong, L.-Y.Hao, C.W.Greider. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107:67-77; PMID:11595186; http://dx.doi.org/10.1016/S0092-8674(01)00504-9
42. L.F.Z.Batista, M.F.Pech, F.L.Zhong, H.N.Nguyen, K.T.Xie, A.J.Zaug, S.M.Crary, J.Choi, V.Sebastiano, A.Cherry, et al. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature 2011; 474:399-402; PMID:21602826; http://dx.doi.org/10.1038/nature10084
43. J.Huang, F.Wang, M.Okuka, N.Liu, G.Ji, X.Ye, B.Zuo, M.Li, P.Liang, W.W.Ge, et al. Association of telomere length with authentic pluripotency of ES/iPS cells. Cell Res 2011; 21:779-92; PMID:21283131; http://dx.doi.org/10.1038/cr.2011.16
44. R.Le, Z.Kou, Y.Jiang, M.Li, B.Huang, W.Liu, H.Li, X.Kou, W.He, K.L.Rudolph, et al. Enhanced telomere rejuvenation in pluripotent cells reprogrammed via nuclear transfer relative to induced pluripotent stem cells. Cell Stem Cell 2014; 14:27-39; PMID:24268696; http://dx.doi.org/10.1016/j.stem.2013.11.005
45. F.Pucci, L.Gardano, L.Harrington. Short Telomeres in ESCs Lead to Unstable Differentiation. Cell Stem Cell 2013; 12:479-86; PMID:23561444; http://dx.doi.org/10.1016/j.stem.2013.01.018
46. T.Q.Dang-Nguyen, S.Haraguchi, T.Furusawa, T.Somfai, M.Kaneda, S.Watanabe, S.Akagi, K.Kikuchi, A.Tajima, T.Nagai. Downregulation of histone methyltransferase genes SUV39H1 and SUV39H2 increases telomere length in embryonic stem-like cells and embryonic fibroblasts in pigs. J Reprod Dev 2013; 59:27-32; PMID:23018532
47. M.L.De Bonis, S.Ortega, M.A.Blasco. SIRT1 is necessary for proficient telomere elongation and genomic stability of induced pluripotent stem cells. Stem cell reports 2014; 2:690-706; PMID:24936455; http://dx.doi.org/10.1016/j.stemcr.2014.03.002
48. C.-C.Tsai, C.L.Chen, H.C.Liu, Y.T.Lee, H.W.Wang, L.T.Hou, S.C.Hung. Overexpression of hTERT increases stem-like properties and decreases spontaneous differentiation in human mesenchymal stem cell lines. J Biomed Sci 2010; 17:10-1186; PMID:20152059; http://dx.doi.org/10.1186/1423-0127-17-10
49. S.Zeng, L.Liu, Y.Sun, P.Xie, L.Hu, D.Yuan, D.Chen, Q.Ouyang, G.Lin, G.Lu. Telomerase-mediated telomere elongation from human blastocysts to embryonic stem cells. J Cell Sci 2014; 127:752-62; PMID:24338368; http://dx.doi.org/10.1242/jcs.131433
50. L.Liu, S.M.Bailey, M.Okuka, P.Muñoz, C.Li, L.Zhou, C.Wu, E.Czerwiec, L.Sandler, A.Seyfang, et al. Telomere lengthening early in development. Nat Cell Biol 2007; 9:1436-41; PMID:17982445; http://dx.doi.org/10.1038/ncb1664
51. M.Zalzman, G.Falco, L.V.Sharova, A.Nishiyama, M.Thomas, S.L.Lee, C.A.Stagg, H.G.Hoang, H.T.Yang, F.E.Indig, et al. Zscan4 regulates telomere elongation and genomic stability in ES cells. Nature 2010; 464:858-63; PMID:20336070; http://dx.doi.org/10.1038/nature08882
52. E.Varela, R.P.Schneider, S.Ortega, M.A.Blasco. Different telomere-length dynamics at the inner cell mass versus established embryonic stem (ES) cells. Proc Natl Acad Sci 2011; 108(37):15207-12; PMID:21873233
53. R.M.Marion, K.Strati, H.Li, A.Tejera, S.Schoeftner, S.Ortega, M.Serrano, M.A.Blasco. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 2009; 4:141-54; PMID:19200803; http://dx.doi.org/10.1016/j.stem.2008.12.010
54. J.Jiang, W.Lv, X.Ye, L.Wang, M.Zhang, H.Yang, M.Okuka, C.Zhou, X.Zhang, L.Liu, et al. Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation. Cell research 2013; 23:92-106; PMID:23147797; http://dx.doi.org/10.1038/cr.2012.157
55. K.Lee, L.Gollahon,. Abstract 2047:The interaction of ZSCAN4 with TRF1:Effects on regulation of telomere elongation in cancer cells. Cancer research 2012; 72:2047; PMID:26403970; http://dx.doi.org/10.1158/1538-7445.AM2012-2047
56. J.Dan, Y.Liu, N.Liu, M.Chiourea, M.Okuka, T.Wu, X.Ye, C.Mou, L.Wang, L.Wang, et al. Rif1 maintains telomere length homeostasis of ESCs by mediating heterochromatin silencing. Developmental cell 2014; 29:7-19; PMID:24735877; http://dx.doi.org/10.1016/j.devcel.2014.03.004
57. R.P.Schneider, I.Garrobo, M.Foronda, J.A.Palacios, R.M.Marión, I.Flores, S.Ortega, M.A.Blasco. TRF1 is a stem cell marker and is essential for the generation of induced pluripotent stem cells. Nature communications 2013; 4:1946; PMID:23735977
58. S.Ozturk, B.Sozen, N.Demir. Telomere length and telomerase activity during oocyte maturation and early embryo development in mammalian species. Molecular human reproduction 2014; 20:15-30; PMID:23928157; http://dx.doi.org/10.1093/molehr/gat055
59. M.A.Blasco. Telomere length, stem cells and aging. Nature chemical biology 2007; 3:640-649; PMID:17876321; http://dx.doi.org/10.1038/nchembio.2007.38
60. L.H.Wong, H.Ren, E.Williams, J.McGhie, S.Ahn, M.Sim, A.Tam, E.Earle, M.A.Anderson, J.Mann, et al. Histone H3. 3 incorporation provides a unique and functionally essential telomeric chromatin in embryonic stem cells. Genome research 2009; 19:404-14; PMID:19196724; http://dx.doi.org/10.1101/gr.084947.108
61. Y.Zhou, P.Zhou, Y.Xin, J.Wang, Z.Zhu, J.Hu, S.Wei, H.Ma. Trend of telomerase activity change during human iPSC self-renewal and differentiation revealed by a quartz crystal microbalance based assay. Sci Rep 2014; 4:6978; PMID:25381797; http://dx.doi.org/10.1038/srep06978
62. E.B.Dashinimaev, et al. Induction of telomerase activity increase reprogramming efficiency of human dermal fibroblasts. Moscow University Biological Sciences Bulletin 2012; 67:6-12; http://dx.doi.org/10.3103/S0096392512010038
63. T.Kinoshita, G.Nagamatsu, S.Saito, K.Takubo, K.Horimoto, T.Suda. Telomerase Reverse Transcriptase Has an Extratelomeric Function in Somatic Cell Reprogramming. Journal of Biological Chemistry 2014; 289:15776-87; PMID:24733392; http://dx.doi.org/10.1074/jbc.M113.536037
64. M.Stadtfeld, N.Maherali, D.T.Breault, K.Hochedlinger. Defining Molecular Cornerstones during Fibroblast to iPS Cell Reprogramming in Mouse. Cell Stem Cell 2008;2:230-40; PMID:18371448; http://dx.doi.org/10.1016/j.stem.2008.02.001
65. K.Hoffmeyer, A.Raggioli, S.Rudloff, R.Anton, A.Hierholzer, I.Del Valle, K.Hein, R.Vogt, R.Kemler. Wnt/β-Catenin Signaling Regulates Telomerase in Stem Cells and Cancer Cells. Science 2012; 336:1549-54; PMID:22723415; http://dx.doi.org/10.1126/science.1218370
66. C.-W.Wong, P.S.Hou, S.F.Tseng, C.L.Chien, K.J.Wu, H.F.Chen, H.N.Ho, S.Kyo, S.C.Teng. Krüppel-Like Transcription Factor 4 Contributes to Maintenance of Telomerase Activity in Stem Cells. Stem Cells 2010; 28:1510-17; PMID:20629177; http://dx.doi.org/10.1002/stem.477
67. Y.Zhang, L.Toh, P.Lau, X.Wang. Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/β-catenin pathway in human cancer. Journal of Biological Chemistry 2012; 287:32494-511; PMID:22854964; http://dx.doi.org/10.1074/jbc.M112.368282
68. R.M.Marion, K.Strati, H.Li, M.Murga, R.Blanco, S.Ortega, O.Fernandez-Capetillo, M.Serrano, M.A.Blasco. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 2009; 460:1149-53; PMID:19668189; http://dx.doi.org/10.1038/nature08287
69. B.D.Rowland, R.Bernards, D.S.Peeper. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 2005; 7:1074-82; PMID:16244670; http://dx.doi.org/10.1038/ncb1314
70. K.Takahashi, S.Yamanaka. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors. Cell 126:663-76; PMID:16904174; http://dx.doi.org/10.1016/j.cell.2006.07.024
71. M.Wernig, A.Meissner, J.P.Cassady, R.Jaenisch. c-Myc Is Dispensable for Direct Reprogramming of Mouse Fibroblasts. Cell Stem Cell 2:10-12; PMID:18371415; http://dx.doi.org/10.1016/j.stem.2007.12.001
72. K.-J.Wu, C.Grandori, M.Amacker, N.Simon-Vermot, A.Polack, J.Lingner, R.Dalla-Favera. Direct activation of TERT transcription by c-MYC. Nat Genet 1999; 21:220-4; PMID:9988278; http://dx.doi.org/10.1038/6010
73. J.Wang, L.Y.Xie, S.Allan, D.Beach, G.J.Hannon. Myc activates telomerase. Gen Dev 1998; 12:1769-74; PMID:9637678; http://dx.doi.org/10.1101/gad.12.12.1769
74. P.Y.Bourillot, I.Aksoy, V.Schreiber, F.Wianny, H.Schulz, O.Hummel, N.Hubner, P.Savatier. Novel STAT3 target genes exert distinct roles in the inhibition of mesoderm and endoderm differentiation in cooperation with Nanog. Stem Cells 2009; 27:1760-71; PMID:19544440; http://dx.doi.org/10.1002/stem.110
75. N.Xu, T.Papagiannakopoulos, G.Pan, J.A.Thomson, K.S.Kosik. MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells. Cell 137:647-58; PMID:19409607; http://dx.doi.org/10.1016/j.cell.2009.02.038
76. N.Erdmann, Y.Liu, L.Harrington. Distinct dosage requirements for the maintenance of long and short telomeres in mTert heterozygous mice. Proc Natl Acad Sci of the United States of America 2004; 101:6080-5; PMID:15079066; http://dx.doi.org/10.1073/pnas.0401580101
77. M.A.Blasco, H.W.Lee, M.P.Hande, E.Samper, P.M.Lansdorp, R.A.DePinho, C.W.Greider. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997; 91:25-34; PMID:9335332; http://dx.doi.org/10.1016/S0092-8674(01)80006-4
78. L.-Y.Sung, W.F.Chang, Q.Zhang, C.C.Liu, J.Y.Liou, C.C.Chang, H.Ou-Yang, R.Guo, H.Fu, W.T.Cheng, et al. Telomere Elongation and Naive Pluripotent Stem Cells Achieved from Telomerase Haplo-Insufficient Cells by Somatic Cell Nuclear Transfer. Cell reports 2014; 9:1603-9; PMID:25464850; http://dx.doi.org/10.1016/j.celrep.2014.10.052
79. B.Feng, J.Jiang, P.Kraus, J.H.Ng, J.C.Heng, Y.S.Chan, L.P.Yaw, W.Zhang, Y.H.Loh, J.Han, et al. Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat Cell Biol 2009; 11:197-203; PMID:19136965; http://dx.doi.org/10.1038/ncb1827
80. N.Festuccia, R.Osorno, F.Halbritter, V.Karwacki-Neisius, P.Navarro, D.Colby, F.Wong, A.Yates, S.R.Tomlinson, I.Chambers. Esrrb is a direct nanog target gene that can substitute for nanog function in pluripotent cells. Cell Stem Cell 2012; 11:477-90; PMID:23040477; http://dx.doi.org/10.1016/j.stem.2012.08.002
81. M.Li, Y.He, W.Dubois, X.Wu, J.Shi, J.Huang. Distinct Regulatory Mechanisms and Functions for p53-Activated and p53-Repressed DNA Damage Response Genes in Embryonic Stem Cells. Molecular Cell 2012; 46:30-42; PMID:22387025; http://dx.doi.org/10.1016/j.molcel.2012.01.020
82. L.Li, S.Wang, A.Jezierski, L.Moalim-Nour, K.Mohib, R.J.Parks, S.F.Retta, L.Wang. A unique interplay between Rap1 and E-cadherin in the endocytic pathway regulates self-renewal of human embryonic stem cells. Stem Cells 2010; 28:247-57; PMID:20039365; http://dx.doi.org/10.1002/stem.532
83. Y.W.Fong, J.J.Ho, C.Inouye, R.Tjian. The dyskerin ribonucleoprotein complex as an OCT4/SOX2 coactivator in embryonic stem cells (ed. B.J.Blencowe,.) Elife 3; e03573 (2014); PMID:25407680
84. C.Yang, S.Przyborski, M.J.Cooke, X.Zhang, R.Stewart, G.Anyfantis, S.P.Atkinson, G.Saretzki, L.Armstrong, et al. A key role for telomerase reverse transcriptase unit in modulating human embryonic stem cell proliferation, cell cycle dynamics, and in vitro differentiation. Stem Cells 2008; 26:850-63; PMID:18203676; http://dx.doi.org/10.1634/stemcells.2007-0677
85. L.Radan, C.S.Hughes, J.H.Teichroeb, F.M.Vieira Zamora, M.Jewer, L.M.Postovit, D.H.Betts. Microenvironmental regulation of telomerase isoforms in human embryonic stem cells. Stem Cells Dev 2014; 23:2046-66; PMID:24749509; http://dx.doi.org/10.1089/scd.2013.0373
86. A.N.Sexton, S.G.Regalado, C.S.Lai, G.J.Cost, C.M.O'Neil, F.D.Urnov, P.D.Gregory, R.Jaenisch, K.Collins, D.Hockemeyer. Genetic and molecular identification of three human TPP1 functions in telomerase action:recruitment, activation, and homeostasis set point regulation. Gen Dev 2014; 28:1885-99; PMID:25128433; http://dx.doi.org/10.1101/gad.246819.114
87. J.Choi, L.K.Southworth, K.Y.Sarin, A.S.Venteicher, W.Ma, W.Chang, P.Cheung, S.Jun, M.K.Artandi, N.Shah, et al. TERT Promotes Epithelial Proliferation through Transcriptional Control of a Myc- and Wnt-Related Developmental Program. PLoS Genet 2008; 4:e10; PMID:18208333; http://dx.doi.org/10.1371/journal.pgen.0040010
88. Y.Cong, J.W.Shay. Actions of human telomerase beyond telomeres. Cell Res 2008; 18:725-32; PMID:18574498; http://dx.doi.org/10.1038/cr.2008.74
89. B.-W.Gu, M.Bessler, P.J.Mason. A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in mice. Proc Natl Acad Sci 2008; 105:10173-8; PMID:18626023; http://dx.doi.org/10.1073/pnas.0803559105
90. K.Y.Sarin. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 2005; 436:1048-52; PMID:16107853; http://dx.doi.org/10.1038/nature03836
91. S.A.Stewart, W.C.Hahn, B.F.O'Connor, E.N.Banner, A.S.Lundberg, P.Modha, H.Mizuno, M.W.Brooks, M.Fleming, D.B.Zimonjic, et al. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci 2002; 99:12606-11; PMID:12193655; http://dx.doi.org/10.1073/pnas.182407599
92. L.L.Smith, H.A.Coller, J.M.Roberts. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol 2003; 5:474-9; PMID:12717449; http://dx.doi.org/10.1038/ncb985
93. I.Flores, M.L.Cayuela, M.A.Blasco. Effects of Telomerase and Telomere Length on Epidermal Stem Cell Behavior. Science 2005; 309:1253-6; PMID:16037417; http://dx.doi.org/10.1126/science.1115025
94. P.Martínez, M.A.Blasco. Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat Rev Cancer 2011; 11:161-76; PMID:21346783; http://dx.doi.org/10.1038/nrc3025
95. M.A.Blasco. Telomerase beyond telomeres. Nat Rev Cancer 2002; 2:627-33; PMID:12154355; http://dx.doi.org/10.1038/nrc862
96. C.Singhapol, D.Pal, R.Czapiewski, M.Porika, G.Nelson, G.C.Saretzki. Mitochondrial telomerase protects cancer cells from nuclear DNA damage and apoptosis. PLoS ONE 2013; 8:9; PMID:23326372; http://dx.doi.org/10.1371/journal.pone.0052989
97. I.R.Indran, M.P.Hande, S.Pervaiz. hTERT Overexpression Alleviates Intracellular ROS Production, Improves Mitochondrial Function, and Inhibits ROS-Mediated Apoptosis in Cancer Cells. Cancer Res 2011; 71:266-76; PMID:21071633; http://dx.doi.org/10.1158/0008-5472.CAN-10-1588
98. E.Nitta, M.Yamashita, K.Hosokawa, M.Xian, K.Takubo, F.Arai, S.Nakada, T.Suda. Telomerase reverse transcriptase protects ATM-deficient hematopoietic stem cells from ROS-induced apoptosis through a telomere-independent mechanism 2011.
99. Z.Liu, P.Wan, H.Duan, J.Zhou, B.Tan, Y.Liu, Q.Zhou, C.Zhou, Z.Huang, B.Tian, et al. ES micro-environment enhances stemness and inhibits apoptosis in human limbal stem cells via the maintenance of telomerase activity. PLoS ONE 2013; 8:e53576; PMID:23326460; http://dx.doi.org/10.1371/journal.pone.0053576
100. M.Mattiussi, G.Tilman, S.Lenglez, A.Decottignies. Human telomerase represses ROS-dependent cellular responses to Tumor Necrosis Factor-α without affecting NF-κB activation. Cellular Signalling 2012; 24:708-17; PMID:22108091; http://dx.doi.org/10.1016/j.cellsig.2011.11.004
101. F.Kong, C.Zheng, D.Xu. Telomerase as a “stemness” enzyme. Science China Life Sciences 2014; 57:564-70; PMID:24829107; http://dx.doi.org/10.1007/s11427-014-4666-6
102. Y.Maida, M.Yasukawa, M.Furuuchi, T.Lassmann, R.Possemato, N.Okamoto, V.Kasim, Y.Hayashizaki, W.C.Hahn, K.Masutomi. An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. Nature 2009; 461:230-5; PMID:19701182; http://dx.doi.org/10.1038/nature08283
103. N.K.Sharma, A.Reyes, P.Green, M.J.Caron, M.G.Bonini, D.M.Gordon, I.J.Holt, J.H.Santos. Human telomerase acts as a hTR-independent reverse transcriptase in mitochondria. Nucleic Acids Res 2011. 40:712-25; PMID:21937513
104. N.Okamoto, M.Yasukawa, C.Nguyen, V.Kasim, Y.Maida, R.Possemato, T.Shibata, K.L.Ligon, K.Fukami, W.C.Hahn, et al. Maintenance of tumor initiating cells of defined genetic composition by nucleostemin. Proc Natl Acad Sci U S A 2011; 108:20388-93; PMID:21730156; http://dx.doi.org/10.1073/pnas.1015171108
105. J.I.Park, A.S.Venteicher, J.Y.Hong, J.Choi, S.Jun, M.Shkreli, W.Chang, Z.Meng, P.Cheung, H.Ji, et al. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 2009; 460:66-72; PMID:19571879; http://dx.doi.org/10.1038/nature08137
106. A.Ghosh, G.Saginc, S.C.Leow, E.Khattar, E.M.Shin, T.D.Yan, M.Wong, Z.Zhang, G.Li, W.K.Sung, et al. Telomerase directly regulates NF-κB-dependent transcription. Nat Cell Biol 2012; 14:1270-1281; PMID:23159929; http://dx.doi.org/10.1038/ncb2621
107. Y.Maida, M.Yasukawa, N.Okamoto, S.Ohka, K.Kinoshita, Y.Totoki, T.K.Ito, T.Minamino, H.Nakamura, S.Yamaguchi, et al. Involvement of telomerase reverse transcriptase in heterochromatin maintenance. Mol Cell Biol 2014; 34:1576-93; PMID:24550003; http://dx.doi.org/10.1128/MCB.00093-14
108. T.Lassmann, Y.Maida, Y.Tomaru, M.Yasukawa, Y.Ando, M.Kojima, V.Kasim, C.Simon, C.O.Daub, P.Carninci, et al. Telomerase Reverse Transcriptase Regulates microRNAs. Int J Mol Sci 2015; 16:1192-208; PMID:25569094; http://dx.doi.org/10.3390/ijms16011192
109. C.T.Hang, J.Yang, P.Han, H.L.Cheng, C.Shang, E.Ashley, B.Zhou, C.P.Chang. Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature 2010; 466:62-67; PMID:20596014; http://dx.doi.org/10.1038/nature09130
110. C.T.Griffin, J.Brennan, T.Magnuson. The chromatin-remodeling enzyme BRG1 plays an essential role in primitive erythropoiesis and vascular development. Development 2008; 135:493-500; PMID:18094026; http://dx.doi.org/10.1242/dev.010090
111. S.Seo, G.A.Richardson, K.L.Kroll. The SWI/SNF chromatin remodeling protein Brg1 is required for vertebrate neurogenesis and mediates transactivation of Ngn and NeuroD. Development 2005; 132:105-15; PMID:15576411; http://dx.doi.org/10.1242/dev.01548
112. S.Bultman, T.Gebuhr, D.Yee, C.La Mantia, J.Nicholson, A.Gilliam, F.Randazzo, D.Metzger, P.Chambon, G.Crabtree, et al. A Brg1 Null Mutation in the Mouse Reveals Functional Differences among Mammalian SWI/SNF Complexes. Mol Cell 2000; 6:1287-95; PMID:11163203; http://dx.doi.org/10.1016/S1097-2765(00)00127-1
113. S.J.Bultman, T.C.Gebuhr, H.Pan, P.Svoboda, R.M.Schultz, T.Magnuson. Maternal BRG1 regulates zygotic genome activation in the mouse. Gen Dev 2006; 20:1744-54; PMID:16818606; http://dx.doi.org/10.1101/gad.1435106
114. I.Listerman, F.S.Gazzaniga, E.H.Blackburn. An investigation of the effects of the core protein telomerase reverse transcriptase on wnt signaling in breast Cancer cells. Mol Cell Biol 2014; 34:280-9; PMID:24216762; http://dx.doi.org/10.1128/MCB.00844-13
115. Z.Liu, Q.Li, K.Li, L.Chen, W.Li, M.Hou, T.Liu, J.Yang, C.Lindvall, M.Björkholm, et al. Telomerase reverse transcriptase promotes epithelial–mesenchymal transition and stem cell-like traits in cancer cells. Oncogene 2013; 32:4203-13; PMID:23045275; http://dx.doi.org/10.1038/onc.2012.441
116. S.Orsulic, O.Huber, H.Aberle, S.Arnold, R.Kemler. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J Cell Sci 1999; 112 (Pt 8), 1237-45; PMID:10085258
117. X.Liu, H.Sun, J.Qi, L.Wang, S.He, J.Liu, C.Feng, C.Chen, W.Li, Y.Guo, et al. Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT–MET mechanism for optimal reprogramming. Nat Cell Biol 2013; 15:829-38; PMID:23708003; http://dx.doi.org/10.1038/ncb2765
118. J.Moslehi, R.A.DePinho, E.Sahin. Telomeres and Mitochondria in the Aging Heart. Circulation Res 2012; 110:1226-37; PMID:22539756; http://dx.doi.org/10.1161/CIRCRESAHA.111.246868
119. G.Saretzki. Extra-telomeric functions of human telomerase:cancer, mitochondria and oxidative stress. Curr Pharmaceutical Design 2014; 20:6386-403; PMID:24975608; http://dx.doi.org/10.2174/1381612820666140630095606
120. D.D.Chang, D.A.Clayton. A novel endoribonuclease cleaves at a priming site of mouse mitochondrial DNA replication. The EMBO Journal 1987; 6:409-17; PMID:3582365
121. J.Rosenbluh, D.Nijhawan, Z.Chen, K.K.Wong, K.Masutomi, W.C.Hahn. RMRP Is a Non-Coding RNA Essential for Early Murine Development. PLoS ONE 2011; 6:e26270; PMID:22039455; http://dx.doi.org/10.1371/journal.pone.0026270
122. Y.Maida, S.Kyo, T.Lassmann, Y.Hayashizaki, K.Masutomi. Off-Target Effect of Endogenous siRNA Derived from RMRP in Human Cells. Int J Mol Sci 2013; 14:9305-18; PMID:23629666; http://dx.doi.org/10.3390/ijms14059305
123. T.I.Drevytska, V.S.Nagibin, V.L.Gurianova, V.R.Kedlyan, A.A.Moibenko, V.E.Dosenko. Silencing of TERT decreases levels of miR-1, miR-21, miR-29a and miR-208a in cardiomyocytes. Cell Biochem Funct 2014; 32:565-70; PMID:25156787; http://dx.doi.org/10.1002/cbf.3051
124. M.A.Strong, S.L.Vidal-Cardenas, B.Karim, H.Yu, N.Guo, C.W.Greider. Phenotypes in mTERT(+)/(−) and mTERT(−)/(−) mice are due to short telomeres, not telomere-independent functions of telomerase reverse transcriptase. Mol Cell Biol 2011; 31:2369-79; PMID:21464209; http://dx.doi.org/10.1128/MCB.05312-11
125. X.Yi, J.W.Shay, W.E.Wright. Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acids Res 2001; 29:4818-25; PMID:11726691; http://dx.doi.org/10.1093/nar/29.23.4818
126. G.A.Ulaner, L.C.Giudice. Developmental regulation of telomerase activity in human fetal tissues during gestation. Mol Hum Reprod 1997; 3:769-73; PMID:9358002; http://dx.doi.org/10.1093/molehr/3.9.769
127. G.A.Ulaner, J.F.Hu, T.H.Vu, L.C.Giudice, A.R.Hoffman. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res 1998; 58:4168-72; PMID:9751630
128. G.A.Ulaner, J.-F.Hu, T.H.Vu, L.C.Giudice, A.R.Hoffman. Tissue-specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development. Int J Cancer 2001; 91:644-9; PMID:11267974; http://dx.doi.org/10.1002/1097-0215(200002)9999:9999%3c::AID-IJC1103%3e3.0.CO;2-V
129. Y.Yokoyama, X.Wan, Y.Takahashi, A.Shinohara, T.Tamaya. Alternatively spliced variant deleting exons 7 and 8 of the human telomerase reverse transcriptase gene is dominantly expressed in the uterus. Mol Hum Reprod 2001; 7:853-7; PMID:11517292; http://dx.doi.org/10.1093/molehr/7.9.853
130. B.R.Graveley. Alternative splicing:increasing diversity in the proteomic world. Trends Genet 2001; 17:100-7; PMID:11173120; http://dx.doi.org/10.1016/S0168-9525(00)02176-4
131. A.Kilian, D.D.Bowtell, H.E.Abud, G.R.Hime, D.J.Venter, P.K.Keese, E.L.Duncan, R.R.Reddel, R.A.Jefferson. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 1997; 6:2011-9; PMID:9328464; http://dx.doi.org/10.1093/hmg/6.12.2011
132. H.Hisatomi, K.Ohyashiki, J.H.Ohyashiki, K.Nagao, T.Kanamaru, H.Hirata, N.Hibi, Y.Tsukada. Expression profile of a gamma-deletion variant of the human telomerase reverse transcriptase gene. Neoplasia 2003; 5:193-7; PMID:12869302; http://dx.doi.org/10.1016/S1476-5586(03)80051-9
133. S.Sæbøe-Larssen, E.Fossberg, G.Gaudernack. Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT):analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues. BMC Mol Biol 2006; 7:26; PMID:16939641
134. J.B.Withers, T.Ashvetiya, K.L.Beemon. Exclusion of exon 2 is a common mRNA splice variant of primate telomerase reverse transcriptases. PLoS One 2012; 7:e48016; PMID:23110161; http://dx.doi.org/10.1371/journal.pone.0048016
135. M.Wick, D.Zubov, G.Hagen. Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene 1999; 232:97-106; PMID:10333526; http://dx.doi.org/10.1016/S0378-1119(99)00108-0
136. S.Wong Mandy, L.Chen, C.Foster, R.Kainthla, J.W.Shay, W.E.Wright. Regulation of Telomerase Alternative Splicing:A Target for Chemotherapy. Cell Rep 2013; 3:1028-35; PMID:23562158; http://dx.doi.org/10.1016/j.celrep.2013.03.011
137. X.Yi, D.M.White, D.L.Aisner, J.A.Baur, W.E.Wright, J.W.Shay. An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. Neoplasia 2000; 2:433-40; PMID:11191110; http://dx.doi.org/10.1038/sj.neo.7900113
138. P.Nicholson, H.Yepiskoposyan, S.Metze, R.Zamudio Orozco, N.Kleinschmidt, O.Mühlemann. Nonsense-mediated mRNA decay in human cells:mechanistic insights, functions beyond quality control and the double-life of NMD factors. Cell Mol Life Sci 2010; 67:677-700; PMID:19859661; http://dx.doi.org/10.1007/s00018-009-0177-1
139. J.H.Santos, J.N.Meyer, M.Skorvaga, L.A.Annab, B.Van Houten,. Mitochondrial hTERT exacerbates free-radical-mediated mtDNA damage. Aging Cell 2004; 3:399-411; PMID:15569357; http://dx.doi.org/10.1111/j.1474-9728.2004.00124.x
140. J.Chung, P.Khadka, I.K.Chung. Nuclear import of hTERT requires a bipartite nuclear localization signal and Akt-mediated phosphorylation. J Cell Sci 2012; 125:2684-97; PMID:22366458; http://dx.doi.org/10.1242/jcs.099267
141. J.Xia, Y.Peng, I.S.Mian, N.F.Lue. Identification of functionally important domains in the N-terminal region of telomerase reverse transcriptase. Mol Cell Biol 2000; 20:5196-207; PMID:10866675; http://dx.doi.org/10.1128/MCB.20.14.5196-5207.2000
142. H.Seimiya, M.Tanji, T.Oh-hara, A.Tomida, I.Naasani, T.Tsuruo. Hypoxia up-regulates telomerase activity via mitogen-activated protein kinase signaling in human solid tumor cells. Biochem Biophys Res Commun 1999; 260:365-70; PMID:10403776; http://dx.doi.org/10.1006/bbrc.1999.0910
143. J.Haendeler, J.Hoffmann, R.P.Brandes, A.M.Zeiher, S.Dimmeler. Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707. Mol Cell Biol 2003; 23:4598-610; PMID:12808100; http://dx.doi.org/10.1128/MCB.23.13.4598-4610.2003
144. K.Arai, K.Masutomi, S.Khurts, S.Kaneko, K.Kobayashi, S.Murakami. Two independent regions of human telomerase reverse transcriptase are important for its oligomerization and telomerase activity. J Biol Chem 2002; 277:8538-44; PMID:11751869; http://dx.doi.org/10.1074/jbc.M111068200
145. S.Jakob, P.Schroeder, M.Lukosz, N.Büchner, I.Spyridopoulos, J.Altschmied, J.Haendeler. Nuclear protein tyrosine phosphatase Shp-2 is one important negative regulator of nuclear export of telomerase reverse transcriptase. J Biol Chem 2008; 283:33155-61; PMID:18829466; http://dx.doi.org/10.1074/jbc.M805138200
146. E.Mavrogiannou, A.Strati, A.Stathopoulou, E.G.Tsaroucha, L.Kaklamanis, E.S.Lianidou. Real-time RT-PCR quantification of human telomerase reverse transcriptase splice variants in tumor cell lines and non-small cell lung cancer. Clin Chem 2007; 53:53-61; PMID:17130181; http://dx.doi.org/10.1373/clinchem.2006.073015
147. L.F.Lincz, L.M.Mudge, F.E.Scorgie, J.A.Sakoff, C.S.Hamilton, M.Seldon. Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variant. Neoplasia 2008; 10:1131-7; PMID:18813352; http://dx.doi.org/10.1593/neo.08644
148. J.H.Ohyashiki, H.Hisatomi, K.Nagao, S.Honda, T.Takaku, Y.Zhang, G.Sashida, K.Ohyashiki. Quantitative relationship between functionally active telomerase and major telomerase components (hTERT and hTR) in acute leukaemia cells. Br J Cancer 2005; 92:1942-7; PMID:15827550; http://dx.doi.org/10.1038/sj.bjc.6602546
149. R.Villa, C.D.Porta, M.Folini, M.G.Daidone, N.Zaffaroni. Possible regulation of telomerase activity by transcription and alternative splicing of telomerase reverse transcriptase in human melanoma. J Invest Dermatol 2001; 116:867-73; PMID:11407973; http://dx.doi.org/10.1046/j.1523-1747.2001.01343.x
150. Y.Liu, B.Q.Wu, H.H.Zhong, X.X.Tian, W.G.Fang. Quantification of alternative splicing variants of human telomerase reverse transcriptase and correlations with telomerase activity in lung cancer. PLoS One 2012; 7:e38868; PMID:22723897; http://dx.doi.org/10.1371/journal.pone.0038868
151. S.Y.Rha, H.C.Jeung, K.H.Park, J.J.Kim, H.C.Chung. Changes of telomerase activity by alternative splicing of full-length and beta variants of hTERT in breast cancer patients. Oncol Res 2009; 18:213-20; PMID:20225759; http://dx.doi.org/10.3727/096504009X12596189659123
152. L.M.Colgin, C.Wilkinson, A.Englezou, A.Kilian, M.O.Robinson, R.R.Reddel. The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia 2000; 2:426-32; PMID:11191109; http://dx.doi.org/10.1038/sj.neo.7900112
153. S.B.Cohen, M.E.Graham, G.O.Lovrecz, N.Bache, P.J.Robinson, R.R.Reddel. Protein composition of catalytically active human telomerase from immortal cells. Science 2007; 315:1850-3; PMID:17395830; http://dx.doi.org/10.1126/science.1138596
154. X.Yi, V.M.Tesmer, I.Savre-Train, J.W.Shay, W.E.Wright. Both transcriptional and posttranscriptional mechanisms regulate human telomerase template RNA levels. Mol Cell Biol 1999; 19:3989-97; PMID:10330139; http://dx.doi.org/10.1128/MCB.19.6.3989
155. S.Mukherjee, E.J.Firpo, Y.Wang, J.M.Roberts. Separation of telomerase functions by reverse genetics. Proc Natl Acad Sci U S A 2011; 108:E1363-71; PMID:21949400; http://dx.doi.org/10.1073/pnas.1112414108
156. J.H.Santos, J.N.Meyer, B.Van Houten. Mitochondrial localization of telomerase as a determinant for hydrogen peroxide-induced mitochondrial DNA damage and apoptosis. Hum Mol Genet 2006; 15:1757-68; PMID:16613901; http://dx.doi.org/10.1093/hmg/ddl098
157. N.Buchner, T.C.Zschauer, M.Lukosz, J.Altschmied, J.Haendeler. Downregulation of mitochondrial telomerase reverse transcriptase induced by H2O2 is Src kinase dependent. Exp Gerontol 2010; 45:558-62; PMID:20211239; http://dx.doi.org/10.1016/j.exger.2010.03.003
158. J.Haendeler, S.Dröse, N.Büchner, S.Jakob, J.Altschmied, C.Goy, I.Spyridopoulos, A.M.Zeiher, U.Brandt, S.Dimmeler. Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage. Arterioscler Thromb Vasc Biol 2009; 29:929-35; PMID:19265030; http://dx.doi.org/10.1161/ATVBAHA.109.185546
159. A.Cerezo, H.Kalthoff, M.Schuermann, B.Schafer, P.Boukamp. Dual regulation of telomerase activity through c-Myc-dependent inhibition and alternative splicing of hTERT. J Cell Sci 2002; 115:1305-12; PMID:11884529
160. C.J.Anderson, S.F.Hoare, M.Ashcroft, A.E.Bilsland, W.N.Keith. Hypoxic regulation of telomerase gene expression by transcriptional and post-transcriptional mechanisms. Oncogene 2006; 25:61-9; PMID:16170363
161. C.E.Forristal, K.L.Wright, N.A.Hanley, R.O.Oreffo, F.D.Houghton. Hypoxia inducible factors regulate pluripotency and proliferation in human embryonic stem cells cultured at reduced oxygen tensions. Reproduction 2010; 139:85-97; PMID:19755485; http://dx.doi.org/10.1530/REP-09-0300
162. S.Turner, H.P.Wong, J.Rai, G.M.Hartshorne. Telomere lengths in human oocytes, cleavage stage embryos and blastocysts. Molecular Human Reproduction 2010; 16:685-694; PMID:20573647; http://dx.doi.org/10.1093/molehr/gaq048
163. M.Akiyama, O.Yamada, T.Hideshima, T.Yanagisawa, K.Yokoi, K.Fujisawa, Y.Eto, H.Yamada, K.C.Anderson. TNFalpha induces rapid activation and nuclear translocation of telomerase in human lymphocytes. Biochem Biophys Res Commun 2004; 316:528-32; PMID:15020249; http://dx.doi.org/10.1016/j.bbrc.2004.02.080